Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Novartis Pharmaceuticals · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
malignant melanoma, dabrafenib, trametinib, adjuvant, stage iii melanoma, combination treatment, pyrexia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 867470
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.